Dr. Nicholas Thomas Lacava, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 360 W Boylston St, Suite 107, West Boylston, MA 01583 Phone: 508-854-1380 Fax: 508-854-0446 |
News Archive
In a study released today in Nature Genetics, researchers have found that Chlamydia has evolved more actively than was previously thought. Using whole genome sequencing the researchers show that the exchange of DNA between different strains of Chlamydia to form new strains is much more common than expected.
Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.
Patients recently diagnosed with Parkinson's disease that have low levels of vitamin B12 develop symptoms faster than those with higher levels, suggesting supplementation could postpone the progression of symptoms, new research has found.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
› Verified 2 days ago